Skip to main content

Table 1 Baseline clinical data from all patients

From: Prediction of invasive candidal infection in critically ill patients with severeacute pancreatitis

  All patients Patients without
invasive candidal
infection
Patients with invasive
candidal infection
P value
Number of patients (%) 101 83 (82.2) 18 (17.8)  
Age, years (median, IQR)) 60 (50 to 73) 60 (50-72) 62.5 (44.75 to 76.25) 0.884
Median LOS ICU (days, IQR, range) 8.9 (3.5 to 17.3, 0.1 to 53.1) 7.3 (3.1 to 14.7, 0.1 to 53.2) 16.9 (9.4 to 23.0, 2.2 to 53.1)a 0.004
Male gender (%) 58 (57.4) 48 (57.8) 10 (55.6) 0.999
Median hospital LOS prior to ICU (days, IQR, range) 4 (1 to 12, 0 to 110) 4 (1 to 12, 0 to 110) 4.5 (2 to 13, 0 to 17) 0.125
APACHE II (median, IQR) 16 (12 to 21) 16 (12 to 20.5) 17 (15 to 21.75) 0.445
Mortality, ICU number (%) 18 (17.8) 13 (15.7) 5 (27.8) 0.305
Hospital number (%) 30 (29.7) 20 (24.1) 10 (55.6)a 0.020
Surgery, number (%) 29 (28.7) 22 (26.5) 7 (38.9) 0.389
Severe sepsis, number (%) 37 (36.6) 30 (36.1) 7 (38.9) 0.999
Significant pancreatic necrosis, number (%) 53 (52.5) 40 (48.2) 13 (72.2) 0.063
Pancreatic intervention, number (%) MIRPN 27 (26.7) 23 (27.7) 4 (22.2) 0.774
  Open necrosectomy 18 (17.8) 11 (13.3) 7 (38.9)a 0.017
  Radiologically-guided drain 5 (5) 4 (4.8) 1 (5.6) 0.999
  Unknown 7 (6.9) 6 (7.2) 1 (5.6) 0.999
  No intervention 44 (44) 39 (47) 5 (27.8) 0.191
Screened for colonisation with candida, number (%) 95 (94.1) 77 (92.8) 18 (100) 0.588
Total body sites screened 340 269 71  
Total sites positive for Candida 107 67 40  
Proportion of sites positive to sites screened 0.31 0.25 0.56  
Aetiology number (%) Gallstones 45 (44.6) 38 (45.8) 7 (38.9) 0.794
  Alcohol 30 (29.7) 25 (30.1) 5 (27.8) 0.999
  Drugs 1 (1) 0 (0) 1 (5.6) 0.178
  Other 10 (9.9) 7 (8.4) 3 (16.7) 0.378
  Idiopathic 3 (3.0) 2 (2.4) 1 (5.6) 0.081
  Unknown 12 (11.9) 10 (12) 2 (11.1) 0.999
  1. aP <0.05. APACHE II, Acute Physiology and Chronic HealthEvaluation II; LOS ICU, length of stay in the ICU; MIRPN, minimally invasiveretroperitoneal pancreatic necrosectomy.